Wire Localization

DEVICE4 trials

Sponsors

Wake Forest University Health Sciences, University of Missouri-Columbia, Peking University, Centre Jean Perrin

Conditions

Breast Neoplasm FemaleBreast TumorBreast- FemaleLymph Node MetastasesNeoadjuvant ChemotherapyNeoplasm, BreastResponse

Unknown Phase

A Trial of RSL Versus WL for Malignant Breast Disease

CompletedNCT02522468

Wake Forest University Health SciencesBreast- Female

Start: 2015-07-24End: 2021-02-23Updated: 2022-08-10

Radiofrequency Chip for Localization of Non-Palpable Breast Lesions

CompletedNCT03684408

University of Missouri-ColumbiaBreast Tumor

Start: 2018-10-18End: 2021-04-19Updated: 2022-08-25

To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes

Peking UniversityLymph Node Metastases, Neoadjuvant Chemotherapy, Neoplasm, Breast +1

Start: 2018-10-20End: 2022-06-30Target: 230Updated: 2021-11-29

Breast Localization: RFID Tags vs Wire Localization

CompletedNCT04750889

Centre Jean PerrinBreast Neoplasm Female

Start: 2021-05-15End: 2023-04-24Updated: 2023-06-18

Related Papers

Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial.

2025-01-223 citations

Diagnostic accuracy of sentinel lymph node biopsy and wire localized clipped node biopsy after neoadjuvant chemotherapy in node-positive breast cancer.

2024-12-27

RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.

2023-07-203 citations